A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.

Source:http://linkedlifedata.com/resource/pubmed/id/11481625

Download in:

View as

Triples

General Info

PMID
11481625